Michael McConnell

Dr. Michael McConnell

Instituto de Salud Carlos III, Madrid, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
MMMichael McConnell
Michael McConnell
LALuis Actis
Luis Actis
JPJerónimo Pachón
Jerónimo Pachón
This review describes the characteristics of Acinetobacter baumannii that have contributed to its emergence as a medically important human pathogen and the anim

1 March 2012 in Infection and Immunity
Verified
Journal Article
Closed access
JGJennifer A. Gaddy
Jennifer A. Gaddy
BABrock A. Arivett
Brock A. Arivett
MMMichael McConnell
Michael McConnell
RLRafael López-Rojas
Rafael López-Rojas
JPJerónimo Pachón
Jerónimo Pachón
LALuis A. Actis
Luis A. Actis
Acinetobacter baumannii , which causes serious infections in immunocompromised patients, expresses high-affinity iron acquisition functions needed for growth under iron-limiting laboratory conditions. In this study, we determined that the initial interaction of the ATCC 19606 T type strain with A549 human alveolar epithelial cells is independent of the production of BasD and BauA, proteins needed for acinetobactin biosynthesis and transport, respectively. In contrast, these proteins are required for this strain to persist within epithelial cells and cause their apoptotic death. Infection assays using Galleria mellonella larvae showed that impairment of acinetobactin biosynthesis and transport functions significantly reduces the ability of ATCC 19606 T cells to persist and kill this host, a defect that was corrected by adding inorganic iron to the inocula. The results obtained with these ex vivo and in vivo approaches were validated using a mouse sepsis model, which showed that expression of the acinetobactin-mediated iron acquisition system is critical for ATCC 19606 T to establish an infection and kill this vertebrate host. These observations demonstrate that the virulence of the ATCC 19606 T strain depends on the expression of a fully active acinetobactin-mediated system. Interestingly, the three models also showed that impairment of BasD production results in an intermediate virulence phenotype compared to those of the parental strain and the BauA mutant. This observation suggests that acinetobactin intermediates or precursors play a virulence role, although their contribution to iron acquisition is less relevant than that of mature acinetobactin.

1 June 2014 in Journal of Proteomics
Verified
Journal Article
Closed access
AOAlfonso Olaya-Abril
Alfonso Olaya-Abril
RPRafael Prados-Rosales
Rafael Prados-Rosales
MMMichael McConnell
Michael McConnell
RMReyes Martín-Peña
Reyes Martín-Peña
JGJosé A. González-Reyes
José A. González-Reyes
Manuel J. Rodríguez-OrtegaManuel J. Rodríguez-Ortega
Manuel J. Rodríguez-Ortega

30 June 2013 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MPMarina Pulido-Ruiz
Marina Pulido-Ruiz
MGMeritxell García-Quintanilla
Meritxell García-Quintanilla
RMReyes Martín-Peña
Reyes Martín-Peña
JCJosé M. Cisneros
José M. Cisneros
MMMichael McConnell
Michael McConnell
Antimicrobial susceptibility testing is essential for guiding the treatment of many types of bacterial infections, especially in the current context of rising rates of antibiotic resistance. The most commonly employed methods rely on the detection of phenotypic resistance by measuring bacterial growth in the presence of the antibiotic being tested. Although these methods are highly sensitive for the detection of resistance, they require that the bacterial pathogen is isolated from the clinical sample before testing and must employ incubation times that are sufficient for differentiating resistant from susceptible isolates. Knowledge regarding the molecular determinants of antibiotic resistance has facilitated the development of novel approaches for the rapid detection of resistance in bacterial pathogens. PCR-based techniques, mass spectrometry, microarrays, microfluidics, cell lysis-based approaches and whole-genome sequencing have all demonstrated the ability to detect resistance in various bacterial species. However, it remains to be determined whether these methods can achieve sufficient sensitivity and specificity compared with standard phenotypic resistance testing to justify their use in routine clinical practice. In the present review, we discuss recent progress in the development of methods for rapid antimicrobial susceptibility testing and highlight the limitations of each approach that still remain be addressed.

1 August 2011 in Vaccine
Verified
Journal Article
Closed access
MMMichael McConnell
Michael McConnell
CRCarlos Rumbo
Carlos Rumbo
GBGermán Bou
Germán Bou
JPJerónimo Pachón
Jerónimo Pachón

8 September 2017 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
JNJ Nowak
J Nowak
EZE E Zander
E E Zander
DSD Stefanik
D Stefanik
PHPaul G. Higgins
Paul G. Higgins
Ignasi RocaIgnasi Roca
Ignasi Roca
HSH Seifert
H Seifert
To investigate the molecular epidemiology, antimicrobial susceptibility and carbapenem resistance determinants of Acinetobacter baumannii isolates from respiratory tract samples of patients diagnosed with ventilator-associated pneumonia (VAP) who were enrolled in the MagicBullet clinical trial. A. baumannii isolates were prospectively cultured from respiratory tract samples from 65 patients from 15 hospitals in Greece, Italy and Spain. Susceptibility testing was performed by broth microdilution. Carbapenem resistance determinants were identified by PCR and sequencing. Molecular epidemiology was investigated using rep-PCR (DiversiLab) and international clones (IC) were identified using our in-house database. Of 65 isolates, all but two isolates (97%) were resistant to imipenem and these were always associated with an acquired carbapenemase, OXA-23 (80%), OXA-40 (4.6%), OXA-58 (1.5%) or OXA-23/58 (1.5%). Resistance to colistin was 47.7%. Twenty-two isolates were XDR, and 20 isolates were pandrug-resistant (PDR). The majority of isolates clustered with IC2 (n = 54) with one major subtype comprising isolates from 12 hospitals in the three countries, which included 19 XDR and 16 PDR isolates. Carbapenem resistance rates were very high in A. baumannii recovered from patients with VAP. Almost half of the isolates were colistin resistant, and 42 (64.6%) isolates were XDR or PDR. Rep-PCR confirmed IC2 is the predominant clonal lineage in Europe and suggests the presence of an epidemic XDR/PDR A. baumannii clone that has spread in Greece, Italy and Spain. These data highlight the difficulty in empirical treatment of patients with A. baumannii VAP in centres with a high prevalence of carbapenem-resistant A. baumannii.